NSCLC
3 stories
-
healthMetastatic NSCLC Treatment Lags in Older Patients Despite Advances
Half of older adults with metastatic NSCLC never receive systemic therapy, despite 15 years of progress.
-
healthAge Alone Should Not Rule Out Lung Cancer Surgery
Study shows lung cancer surgery is safe and effective for carefully selected patients aged 80 and older with early-stage NSCLC.
-
healthTiming is Key: Early Immunochemotherapy Dramatically Boosts Lung Cancer Survival
New trial data reveals that delivering immunochemotherapy earlier in advanced non-small cell lung cancer patients significantly improves progression-free and overall survival.